128 related articles for article (PubMed ID: 12939789)
1. Anti-dipsotropic isoflavones: the potential therapeutic agents for alcohol dependence.
Keung WM
Med Res Rev; 2003 Nov; 23(6):669-96. PubMed ID: 12939789
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of daidzin analogues as potential agents for alcohol abuse.
Gao GY; Li DJ; Keung WM
Bioorg Med Chem; 2003 Sep; 11(18):4069-81. PubMed ID: 12927869
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of potential antidipsotropic isoflavones: inhibitors of the mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway.
Gao GY; Li DJ; Keung WM
J Med Chem; 2001 Sep; 44(20):3320-8. PubMed ID: 11563931
[TBL] [Abstract][Full Text] [Related]
4. The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
Rooke N; Li DJ; Li J; Keung WM
J Med Chem; 2000 Nov; 43(22):4169-79. PubMed ID: 11063613
[TBL] [Abstract][Full Text] [Related]
5. Biogenic aldehyde(s) derived from the action of monoamine oxidase may mediate the antidipsotropic effect of daidzin.
Keung WM
Chem Biol Interact; 2001 Jan; 130-132(1-3):919-30. PubMed ID: 11306106
[TBL] [Abstract][Full Text] [Related]
6. Daidzin and its antidipsotropic analogs inhibit serotonin and dopamine metabolism in isolated mitochondria.
Keung WM; Vallee BL
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2198-203. PubMed ID: 9482862
[TBL] [Abstract][Full Text] [Related]
7. Daidzin inhibits mitochondrial aldehyde dehydrogenase and suppresses ethanol intake of Syrian golden hamsters.
Keung WM; Klyosov AA; Vallee BL
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1675-9. PubMed ID: 9050837
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
Youdim MB; Weinstock M
Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR analysis.
Medvedev AE; Ramsay RR; Ivanov AS; Veselovsky AV; Shvedov VI; Tikhonova OV; Barradas AP; Davidson CK; Moskvitina TA; Fedotova OA; Axenova LN
Neurobiology (Bp); 1999; 7(2):151-8. PubMed ID: 10591049
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
11. The effect of ethanol consumption on the sensitivity of rat brain monoamine oxidases to the inhibition by pargyline in vivo and in vitro.
Panova NG; Axenova LN; Medvedev AE
Neurobiology (Bp); 2000; 8(3-4):225-30. PubMed ID: 11225512
[TBL] [Abstract][Full Text] [Related]
12. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE
J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of monoamine oxidase B by analogues of the adenosine A2A receptor antagonist (E)-8-(3-chlorostyryl)caffeine (CSC).
Vlok N; Malan SF; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2006 May; 14(10):3512-21. PubMed ID: 16442801
[TBL] [Abstract][Full Text] [Related]
14. Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins.
Carotti A; Altomare C; Catto M; Gnerre C; Summo L; De Marco A; Rose S; Jenner P; Testa B
Chem Biodivers; 2006 Feb; 3(2):134-49. PubMed ID: 17193252
[TBL] [Abstract][Full Text] [Related]
15. Fluorinated phenylcyclopropylamines. Part 4: effects of aryl substituents and stereochemistry on the inhibition of monoamine oxidases by 1-aryl-2-fluoro-cyclopropylamines.
Ye S; Yoshida S; Fröhlich R; Haufe G; Kirk KL
Bioorg Med Chem; 2005 Apr; 13(7):2489-99. PubMed ID: 15755651
[TBL] [Abstract][Full Text] [Related]
16. Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction.
van Amsterdam J; Talhout R; Vleeming W; Opperhuizen A
Life Sci; 2006 Oct; 79(21):1969-73. PubMed ID: 16884739
[TBL] [Abstract][Full Text] [Related]
17. Fluorinated phenylcyclopropylamines. Part 3: Inhibition of monoamine oxidase A and B.
Yoshida S; Rosen TC; Meyer OG; Sloan MJ; Ye S; Haufe G; Kirk KL
Bioorg Med Chem; 2004 May; 12(10):2645-52. PubMed ID: 15110846
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of monoamine oxidase B by selected benzimidazole and caffeine analogues.
van den Berg D; Zoellner KR; Ogunrombi MO; Malan SF; Terre'Blanche G; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2007 Jun; 15(11):3692-702. PubMed ID: 17416530
[TBL] [Abstract][Full Text] [Related]
19. On the role of monoamine oxidase-A for the maintenance of the volitional consumption of ethanol in two different rat models.
Mega BT; Sheppard KW; Williams HL; McMillen BA
Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):319-26. PubMed ID: 12237745
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
